Objective: To investigate T cell and antibody immunity to Epstein-Barr virus (EBV) in multiple sclerosis (MS)

Burrows, S R

Csurhes, P A

Lenarczyk, A

Pender, M P

Pfluger, C M M

English

PubMed

Pender, Michael P.

Csurhes, Peter A.

Lenarczyk, Aleksandra

Pfluger, Casey M. M.

Burrows, S. R.

University of Queensland eSpace

Decreased T cell reactivity to Epstein–Barr virus infected lymphoblastoid cell lines in multiple sclerosis

M P Pender

P A Csurhes

A Lenarczyk

C M M Pfluger

S R Burrows

Crossref

Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis

Altered CD8 + T cell responses to selected Epstein–Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin Exp Immunol

An altered immune response to Epstein–Barr virus in multiple sclerosis: a prospective study.

Application of the ELISPOT assay to the characterization of CD8 + responses to Epstein–Barr virus antigens.

CD8 + immunodominance among Epstein–Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells.

Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein–Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.

Complex systems.

Correlation of blood T cell and antibody reactivity to myelin proteins with HLA type and lesion localization in multiple sclerosis.

Cytotoxic CD8 + T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts. Immunodominance is elicited by a peptide epitope that is presented at low levels in vitro.

Diagnostic criteria for multiple sclerosis:

Dysregulated Epstein–Barr virus infection in the multiple sclerosis brain.

Environmental risk factors for multiple sclerosis. Part I: The role of infection.

Epitope focusing in the primary cytotoxic T cell response to Epstein–Barr virus and its relationship to T cell memory.

Epstein–Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis.

Epstein–Barr virus antibodies and risk of multiple sclerosis: a prospective study.

Epstein–Barr virus: exploiting the immune system.

Frequency analysis of HLA-B7-restricted Epstein–Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls.

Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens

High seroprevalence of Epstein–Barr virus in children with multiple sclerosis.

Identification of Epstein–Barr virus proteins as putative targets of the immune response in multiple sclerosis.

Immunology of multiple sclerosis. Annu Rev Immunol

Immunology of multiple sclerosis. Curr Allergy Asthma Rep

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

Increased prevalence and titer of Epstein–Barr virus antibodies in patients with multiple sclerosis.

Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Non-linear dynamics for clinicians: chaos theory, fractals, and complexity at the bedside. Lancet

Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Selective accumulation of virus-specific CD8 + T cells with unique homing phenotype within the human bone marrow. Blood 2008;112:3293–302.

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.

T cells and viral persistence: lessons from diverse infections.

T-cell-mediated suppression of Epstein–Barr virusinduced B lymphocyte activation in multiple sclerosis. Clin Immunol Immunopathol

Temporal relationship between elevation of Epstein–Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.

The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2663364

Decreased T cell reactivity to Epstein–Barr virus infected lymphoblastoid cell lines in multiple sclerosis

Abstract

Similar works

Full text

Available Versions

University of Queensland eSpace

Crossref